首页> 外文会议>International Joint Conference on Neural Networks >Application of artificial neural network and multiple linear regression models for predicting survival time of patients with non-small cell cancer using multiple prognostic factors including FDG-PET measurements
【24h】

Application of artificial neural network and multiple linear regression models for predicting survival time of patients with non-small cell cancer using multiple prognostic factors including FDG-PET measurements

机译:人工神经网络和多元线性回归模型在使用包括FDG-PET测量的多重预后因子预测非小细胞癌患者存活时间

获取原文
获取外文期刊封面目录资料

摘要

We hypothesize and demonstrate that artificial neural networks (ANN) can perform better than multiple linear regression models in overcoming the limitations of the current TNM staging system for predicting the overall survival time of patients with non-small cell lung cancer (NSCLC). Better prognostication of survival was achieved by including additional prognostic factors, such as FDG-PET measurements and other clinical and pathological prognostic factors. The use of an ANN resulted in a substantial improvement in correlation between actual and predicted months of survival in 328 patients with NSCLC. The ANN resulted in an increase in R2, from 0.66 to 0.774, and a reduction in standard deviation, from 17.4 months to 14 months, when compared to multiple linear regressions. Furthermore, the cross-validation results of R2=0.608 suggests that the ANN model was capable of predicting survival for patients who were not included in the database for building the ANN model.
机译:我们假设并证明人工神经网络(ANN)可以优于多元线性回归模型来克服当前TNM分期系统的局限性,以预测非小细胞肺癌(NSCLC)的总生存时间。通过包括额外的预后因素,例如FDG-PET测量和其他临床和病理预后因素,可以实现更好的存活预测。 ANN的使用导致328例NSCLC患者实际和预测月份的生存之间的相关性大幅提高。与多元线性回归相比,r2的R2增加0.66至0.774,标准差减少,从17.4个月减少到14个月。此外,R2 = 0.608的交叉验证结果表明,ANN模型能够预测不包括在数据库中建立ANN模型的患者的生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号